首页> 外文OA文献 >Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63
【2h】

Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63

机译:严重急性呼吸综合征冠状病毒感染患者的血清学反应与人冠状病毒229E,OC43和NL63的交叉反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The serological response profile of severe acute respiratory syndrome (SARS) coronavirus (CoV) infection was defined by neutralization tests and subclass-specific immunofluorescent (IF) tests using serial sera from 20 patients. SARS CoV total immunoglobulin (Ig) (IgG, IgA, and IgM [IgGAM]) was the first antibody to be detectable. There was no difference in time to seroconversion between the patients who survived (n = 14) and those who died (n = 6). Although SARS CoV IgM was still detectable by IF tests with 8 of 11 patients at 7 months postinfection, the geometric mean titers dropped from 282 at 1 month postinfection to 19 at 7 months (P = 0.001). In contrast, neutralizing antibody and SARS CoV IgGAM and IgG antibody titers remained stable over this period. The SARS CoV antibody response was sometimes associated with an increase in preexisting IF IgG antibody titers for human coronaviruses OC43, 229E, and NL63. There was no change in IF IgG titer for virus capsid antigen from the herpesvirus that was used as an unrelated control, Epstein-Barr virus. In contrast, patients who had OC43 infections, and probably also 229E infections, without prior exposure to SARS CoV had increases of antibodies specific for the infecting virus but not for SARS CoV. There is a need for awareness of cross-reactive antibody responses between coronaviruses when interpreting IF serology. Copyright © 2005, American Society for Microbiology. All Rights Reserved.
机译:严重急性呼吸系统综合症(SARS)冠状病毒(CoV)感染的血清学反应谱通过中和试验和亚类特异性免疫荧光(IF)试验确定,其中使用了来自20例患者的连续血清。 SARS CoV总免疫球蛋白(Ig)(IgG,IgA和IgM [IgGAM])是第一个可检测的抗体。存活的患者(n = 14)和死亡的患者(n = 6)的血清转化时间没有差异。尽管在感染后7个月的11例患者中有8例仍可通过IF测试检测到SARS CoV IgM,但几何平均滴度从感染后1个月的282降至7个月时的19(P = 0.001)。相反,在此期间,中和抗体以及SARS CoV IgGAM和IgG抗体滴度保持稳定。 SARS CoV抗体反应有时与人冠状病毒OC43、229E和NL63的IF IgG抗体滴度增加有关。疱疹病毒的衣壳抗原的IF IgG滴度没有变化,而疱疹病毒被用作无关的对照,爱泼斯坦-巴尔病毒。相反,在未事先暴露于SARS CoV的情况下,患有OC43感染以及可能还有229E感染的患者的感染病毒特异性抗体增加,但SARS CoV没有特异性。在解释IF血清学时,需要了解冠状病毒之间的交叉反应性抗体反应。美国微生物学会版权所有©2005。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号